Ildong Pharmaceutical Co., Ltd.(KR:249420)
₩11,870.00-420.00 (-3.42%)
KR:249420
Ildong Pharmaceutical Co., Ltd. Revenue
₩11,870.00
At close:-420.00 (-3.42%)
Want to see KR:249420 full AI Analyst Report?
Ildong Pharmaceutical Co., Ltd. (249420) Revenue
Ildong Pharmaceutical Co., Ltd. Revenue
Ildong Pharmaceutical Co., Ltd. had a revenue of 150.96B in the quarter ending Sep 30, 2026, with 2.09%. This bring the company's revenue in the last twelve months to 587.84B, Increased 0.94%. In the fiscal year ending Dec 31, 2025, Ildong Pharmaceutical Co., Ltd. had annual revenue of 566.93B with -7.81% growth.
- Revenue (ttm)
- 587.84B
- Revenue Growth
- 2.12%
- P/S Ratio
- 0.69
- Revenue/Employee
- KRW 513,526,937
- Employees
- 1,104
- Market Cap
- KRW 388.61B
Revenue Chart
Ildong Pharmaceutical Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 566.93B | -48.01B | -7.81% |
| Dec 31, 2024 | 614.94B | 14.18B | 2.36% |
| Dec 31, 2023 | 600.76B | -36.96B | -5.80% |
| Dec 31, 2022 | 637.71B | 77.58B | 13.85% |
| Dec 31, 2021 | 560.13B | -1.71B | -0.30% |
| Dec 31, 2020 | 561.85B | 44.38B | 8.58% |
| Dec 31, 2019 | 517.47B | 13.56B | 2.69% |
| Dec 31, 2018 | 503.91B | 43.26B | 9.39% |
| Dec 31, 2017 | 460.65B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

